Active Ingredient History

  • Now
Farampator is an ampakine drug. It was developed by Cortex Pharmaceuticals, and licensed to Organon BioSciences for commercial development. Following the purchase of Organon by Schering-Plough in 2007, the development license to farampator was transferred. The development of farampator was eventually terminated, reportedly due to concerns about cardiac toxicity.   Wikipedia

  • SMILES: O=C(N1CCCCC1)c2ccc3nonc3c2
  • Mol. Mass: 231.25
  • ALogP: 1.85
  • ChEMBL Molecule:
More Chemistry
1-(benzofurazan-5-ylcarbonyl)piperidine | 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole | cx-691 | farampator | org 24448 | org-24448 | sch 900460 | sch-900460


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue